Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
Clinical trial NCT02430714 · COMPLETED
Trial details
- NCT number
- NCT02430714
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-05-20
- Primary completion
- 2016-11-06
- Enrollment
- 629
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.